Title: Three basic types of journals
1Three basic types of journals
- Selective-commercial (Cell, Nature)
- Selective-not for profit (JCB, Science, Genes
Development, AJP, PLoS) - Non-selective, archival (commercial, BioMed
Central)
2Importance of selective, non-profit journals
- Account for only 5 of all scientific journals
- Yet, they comprise 44 of the top 100 most highly
cited biomedical journals (ISI, 2003) - Nearly half of all citations
3Importance of selective, non-profit journals
- A disproportionately important forum for
scientific communication - So, it is essential to the scientific community
that the viability of this forum not be risked - Not part of the problem, but rather, essential to
the solution
4Importance of selective, non-profit journals
- Run by and for the scientific community, not for
corporate masters - Provide an essential post-laboratory quality
control - Absence of profit motive and dedication to the
community has fostered innovation
5Innovations promoted by non-profits
- On-line publication HighWire Press at Stanford
- Self-funding archiving projects, fellowships,
outreach - Standards for digital data integrity (JCB/NIH)
- Free sharing/distribution of reagents
- via National Academy
- Addgene, Inc. initiative
6The JCB and access
- Founding and leading journal in the field
- Low subscription rates (1500 site license fee,
1/year/scientist at Yale) - Reasonable page charges
- First to release content after 6 months (in
response to the original PLoS boycott) - Content released free to 142 developing nations
from moment of publication
7The JCB and service
- First to provide free on line access to
historical archive (from 1954, vol 1, issue 1) - All review and editing by colleagues, not
professionals - Rapid turnaround (3-4 wks) and publication
- Well received news and analysis features
8The JCB and access
- We support all experiments with new models of
access, and will embrace anything that can be
shown to work without risking a forum on which
the scientific community depends. - We are in business to promote scientific
communication, not profits - So, why not simply go open access?
9Costs of publication
- Despite modest operation, costs approach
8000/article (even online only) - Only 15 submitted papers accepted
- Two full time editors
- Staff for review, on line publishing, archiving
- About average for all journals (some more, some
less) - Author pays model unacceptable only wealthy
labs could afford publication
10The track record thus far
- Only 54 of PNAS authors would be willing to pay
a surcharge for open access, and 84 of those are
only willing to pay 500. - Mixed models have led to 10 participation.
-
- J Clin Invest charges 2,700/article for open
access, but relies on subscriptions for 50 of
its revenue (and has society backing) - Br Med J has abandoned free access after
subscriptions fell
11The PLoS model?
- A highly selective non-profit
- 1,500 per paper (author pays)
- Financial details never revealed
- Reliance on major philanthropy (9MM grant)
12Unfortunately, the execution of PLoS has caused
some problems
- Philanthropic support is practical for only a
select few. - It is dangerous not to reveal true costs when
making policy mandated underfunding
13Unfortunately, the execution of PLoS has caused
counterproductive problems
- Reliance on legislative and public relations
solutions invites further intrusion of national
politics into science. - Ignores and threatens the survival of other
non-profits, the natural and proven supporters of
scientific communication and service to the
community
14Making the transition open access
- Realistic access (6 month release, low cost) as
a good current compromise - Focus of current NIH guidelines
- Vast majority of scientists have immediate access
due to site licenses - General public has reasonable access
- Alternative pathways to more complete access can
be safely explored - Market, not ideology, should determine success
15Making the transition open access
- PLoS should work together and co-exist with the
non-profit sector to further speed innovation - PLoS should not seek to impose an unproven model
too much at risk for too little gain - Selective commercial journals exist because they
provide a desireable forum, and should be allowed
to compete but persuaded to provide realistic
access
16Making the transition open access
- Majority of current library cost reflects
non-selective, commercial journals - Non-profits can compete here by providing low
cost, open access archives as attractive
alternatives to libraries and scientists - High paper throughput, low review/editing costs
favorable to author pays model - Cytopedia a reviewed open access repository
17Quo vadis?
- Government/funding agency subsidies?
- Increase institutional site license fees in
exchange for free access to papers from that
institution? - Evolutionary improvments have been dramatic why
not just continue?